A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)

PHASE3CompletedINTERVENTIONAL
Enrollment

206

Participants

Timeline

Start Date

August 21, 2023

Primary Completion Date

October 9, 2024

Study Completion Date

October 9, 2024

Conditions
Type 2 Diabetes
Interventions
DRUG

Tirzepatide

Administered SC

DRUG

Placebo

Administered SC

Trial Locations (28)

100853

Chinese PLA General Hospital, Beijing

116001

Dalian University - The Affiliated Zhongshan Hospital, Dalian

116033

Dalian Municipal Central Hospital Affiliated of Dalian Medical University, Dalian

124009

Panjin Liaoyou Baoshihua Hospital, Liaoyou

150001

The Fourth Affiliated Hospital of Harbin Medical University, Harbin

201200

Pudong New Area People's Hospital Shanghai, Shanghai

201800

Jiading District Central Hospital, Shanghai

210011

The Second Affiliated Hospital of Nanjing Medical University, Nanjing

210012

Nanjing First Hospital, Nanjing

211100

Nanjing Medical University - Nanjing Jiangning Hospital, Nanjing

212000

Affiliated Hospital of Jiangsu University, Zhenjiang

215006

The First Affiliated Hospital of Soochow University, Suzhou

250013

Jinan Central Hospital, Jinan

300052

Tianjin Medical University General Hospital, Tianjin

313000

Huzhou Central Hospital, Huzhou

337055

Jiangxi Pingxiang People's Hospital, Pingxiang

415003

The First People's Hospital of Changde City, Changde

443003

Yichang Central People's Hospital, Yichang

450014

The Second Affiliated Hospital of Zhengzhou University, Zhengzhou

471003

The First Affiliated Hospital of Henan University of Science &Technology, Luoyang Shi

473007

The First Affiliated Hospital of Nanyang Medical College, Nanyang

516001

Huizhou Municipal Central Hospital, Huizhou

528399

Shunde Hospital of Southern Medical Univesity, Foshan

563002

Zunyi First People's Hospital, Zunyi

570311

Hainan General Hospital, Haikou

610041

West China Hospital of Sichuan University, Chengdu

611130

Chengdu Fifth People's Hospital, Chengdu

710077

The First Affiliated Hospital of Xi'an Medical University, Xi'an

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY